: Pharmacotherapy involving hormones and hormone-derived molecules has various potential treatment targets. This includes addressing (partial) hormonal deficiencies, pursuing osteoanabolic effects, providing contraceptive options, or supporting gender-affirming transitions. In chronotherapy, the timing of the administration of active ingredients and different pharmaceutical forms is leveraged to maximize therapeutic efficacy while minimizing adverse effects, based on the principle that it is optimal for drugs to be administered according to the body's circadian rhythms. Just as a drummer sets the pace and keeps the rhythm steady for the entire band, the physician, through the application of chronotherapy, ensures the treatment regimen is harmonized with the body's internal clock. However, while this is a consolidated aspect for several endocrine treatments, for others, it represents a novelty. The new advancements in the treatment of osteoporosis, with the latest Parathyroid Hormone-Related Protein analogue abaloparatide, or in congenital adrenal hyperplasia with the new long-lasting hydrocortisone formulation, are notable examples. We herein summarized the state-of-the-art regarding the hormonal circadian rhythm to discuss in depth the evidence available regarding the correct timing of commonly administered hormonal therapies in adult patients. By offering clear indications this manuscript delves into the importance of harmonizing hormonal therapy with circadian rhythms through chronotherapy, exploring its potential to enhance therapeutic outcomes while minimizing adverse effects.

The Chronobiology of Hormone Administration: "Doctor, what time should I take my medication?" / Colonnello, Elena; Graziani, Andrea; Rossetti, Rebecca; Voltan, Giacomo; Masi, Davide; Lubrano, Carla; Mariani, Stefania; Watanabe, Mikiko; Isidori, Andrea M; Ferlin, Alberto; Gnessi, Lucio. - In: ENDOCRINE REVIEWS. - ISSN 0163-769X. - (2025). [10.1210/endrev/bnaf013]

The Chronobiology of Hormone Administration: "Doctor, what time should I take my medication?"

Colonnello, Elena;Rossetti, Rebecca;Masi, Davide;Lubrano, Carla;Mariani, Stefania;Watanabe, Mikiko
;
Isidori, Andrea M;Gnessi, Lucio
2025

Abstract

: Pharmacotherapy involving hormones and hormone-derived molecules has various potential treatment targets. This includes addressing (partial) hormonal deficiencies, pursuing osteoanabolic effects, providing contraceptive options, or supporting gender-affirming transitions. In chronotherapy, the timing of the administration of active ingredients and different pharmaceutical forms is leveraged to maximize therapeutic efficacy while minimizing adverse effects, based on the principle that it is optimal for drugs to be administered according to the body's circadian rhythms. Just as a drummer sets the pace and keeps the rhythm steady for the entire band, the physician, through the application of chronotherapy, ensures the treatment regimen is harmonized with the body's internal clock. However, while this is a consolidated aspect for several endocrine treatments, for others, it represents a novelty. The new advancements in the treatment of osteoporosis, with the latest Parathyroid Hormone-Related Protein analogue abaloparatide, or in congenital adrenal hyperplasia with the new long-lasting hydrocortisone formulation, are notable examples. We herein summarized the state-of-the-art regarding the hormonal circadian rhythm to discuss in depth the evidence available regarding the correct timing of commonly administered hormonal therapies in adult patients. By offering clear indications this manuscript delves into the importance of harmonizing hormonal therapy with circadian rhythms through chronotherapy, exploring its potential to enhance therapeutic outcomes while minimizing adverse effects.
2025
chronobiology; chronotypes; circadian rhythm; glucocorticoids; hormone replacement; pharmacotherapy
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
The Chronobiology of Hormone Administration: "Doctor, what time should I take my medication?" / Colonnello, Elena; Graziani, Andrea; Rossetti, Rebecca; Voltan, Giacomo; Masi, Davide; Lubrano, Carla; Mariani, Stefania; Watanabe, Mikiko; Isidori, Andrea M; Ferlin, Alberto; Gnessi, Lucio. - In: ENDOCRINE REVIEWS. - ISSN 0163-769X. - (2025). [10.1210/endrev/bnaf013]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1737567
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact